Results 81 to 90 of about 5,144 (141)

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis. [PDF]

Acta Derm Venereol
Watanabe A, Kamata M, Okada Y, Hayashi K, Tada Y.   +4 more
europepmc   +1 more source

Ixekizumab-induced cutaneous vasculitis: A rare challenge in the era of biologic therapies. [PDF]

JAAD Case Rep
Benavides Tulcán EY, Vanegas Arciniegas SI, Lozano Ponce EA.   +2 more
europepmc   +1 more source

Glucagon-like peptide-1-based therapies and the intersection of metabolic and skin disease. [PDF]

JAAD Case Rep
Ormaza-Vera A, Enos CW.
europepmc   +1 more source

The IL-23/-17 Axis in PsA: What Have We Learned in the Last 20 Years? [PDF]

Mediterr J Rheumatol
Theodoridou F, Katsouli O, Fragoulis GE.
europepmc   +1 more source

Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons. [PDF]

Acta Derm Venereol
Ding Y, Liu W.
europepmc   +1 more source

IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients. [PDF]

J Dermatol
Takahashi T, Takahashi T, Segawa Y, Oka K, Takahashi T, Asano Y.   +5 more
europepmc   +1 more source

Successful treatment of recalcitrant Hailey-Hailey disease with ixekizumab. [PDF]

JAAD Case Rep
Bohrnstedt G, Bohrnstedt K, Carter W.
europepmc   +1 more source

Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study. [PDF]

Dermatol Ther (Heidelb)
Gisondi P, Girolomoni G.
europepmc   +1 more source

Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.

JAMA Dermatol
Lebwohl M, Blauvelt A, Kartman CE, Leatherwood C, Gordon KB, Sattar N, Puig L, Merola JF, Siu K, Wang R, Sun L, Leung A, Somani N, Rueda MJ, Cardoso A, Genovese MC, Armstrong AW, Strober B.   +17 more
europepmc   +1 more source

Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials. [PDF]

Rheumatol Ther
Sengupta R, Machado PM, Goupille P, Rudwaleit M, Sheesh M, Ng KJ, Ngantcha M, Yan Y, Russ H, Doridot G, Xue Y, Poddubnyy D, Baraliakos X, Navarro-Compán V.   +13 more
europepmc   +1 more source